South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial

South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial  – SRP-001, a novel, non-opioid investigational drug that avoids the liver toxicity associated with acetaminophen, positioned to address the unmet medical need for non-toxic and non-addictive acute and chronic pain therapeutics –  – Data expected in 3Q 2023 – NEW … Read more

Erin Berg Introduced as Director of Project Management at Lotus Clinical Research

We are very excited to introduce Erin Berg as our Director of Project Management at Lotus Clinical Research. In her role, Erin will be leveraging her extensive experience to oversee and deliver Early Development Service (EDS) trials. With a wealth of experience and a proven track record of success in global project management and clinical study … Read more

Lotus and ERG effectively kick off their inaugural internal CRA Academy!

Lotus and ERG effectively kick off their inaugural internal CRA Academy! Cassie Witte asks the creator and facilitator of the CRA Academy, Marilyn Greenwalt, and two of the Academy’s graduates Cooper Nelson and Nicole Johnson, some questions about this initiative. Interested in learning more about our CRA Academy? Check out the video below!

Pacira Biosciences Announces Positive Topline Data From Phase 3 Study of Exparel as a Single-Dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty

News & Press Lotus Clinical Research worked closely with Pacira on this successful pivotal Phase 3 trial in total knee arthroplasty (TKA), providing scientific consulting and conducting the study within our CRO and the ERG site network. ERG-Lotus was able enroll this study far more rapidly than a typical TKA study, while employing a relatively … Read more

Neil Singla, MD- Public Comments on FDA’s February 2022 Draft Guidance for Industry

Below please find my comments on FDA’s draft document: Development of Non-Opioid Analgesics for Acute Pain: Guidance for Industry, dated February 7, 2022. I am a board-certified anesthesiologist and Chief Scientific Officer of Lotus Clinical Research, LLC, a contract research organization, regulatory consulting firm and research site network specializing in analgesic clinical trials.